ID
4765
Description
A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Non-metastatic Hormone Resistant Prostate Cancer (ENTHUSE M0) see http://clinicaltrials.gov/ct2/show/study/NCT00626548
Link
http://clinicaltrials.gov/ct2/show/study/NCT00626548
Keywords
Versions (5)
- 11/22/11 11/22/11 -
- 11/22/11 11/22/11 -
- 3/27/14 3/27/14 - Martin Dugas
- 4/13/14 4/13/14 - Julian Varghese
- 9/17/21 9/17/21 -
Uploaded on
March 27, 2014
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0 Legacy
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility NCT00626548 Prostate Cancer
Eligibility NCT00626548
- StudyEvent: Eligibility
Description
Exclusion criteria
Alias
- UMLS CUI-1
- C0680251
Description
Opiate
Data type
boolean
Alias
- UMLS CUI-1
- C0376196
Description
Previous chemotherapy
Data type
boolean
Alias
- UMLS CUI-1
- C1514457
Description
Heart disease
Data type
boolean
Alias
- UMLS CUI-1
- C0018799
Description
Epilepsy
Data type
boolean
Alias
- UMLS CUI-1
- C0014544
Similar models
Eligibility NCT00626548
- StudyEvent: Eligibility